Young Joseph R
SVP, Finance, Chief Acct Offcr | SVP, Finance, Chief Acct Offcr
1 company
Insider Signal Score
58
GoodTrades Analyzed
5
12M Win Rate
75.0%
Avg 3M Return
-4.0%
Avg 12M Return
+20.3%
Young Joseph R is a SVP, Finance, Chief Acct Offcr at Vera Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $2.6M based on current market prices.
Holdings by Company
VERAFeb 4, 2026
Current Shares67.8K
Value$2.59M
Net Activity-45,837
Bought: 5.7KSold: 51.6K
Transaction History
Showing 4 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | VERA Vera Therapeutics, Inc. | SVP, Finance, Chief Acct Offcr | Sale+OE | 15,000 | $29.06 | $435,874.50 | -23.9% | +47.6% | - | |
| May 16, 2024 | VERA Vera Therapeutics, Inc. | SVP, Finance, Chief Acct Offcr | Sale+OE | 30,837 | $42.30 | $1,304,435.34 | -13.0% | -9.6% | -49.3% | |
| Apr 10, 2024 | VERA Vera Therapeutics, Inc. | SVP, Finance, Chief Acct Offcr | Sell | 5,714 | $40.00 | $228,560.00 | -9.7% | -15.8% | -47.6% | |
| Feb 6, 2022 | VERA Vera Therapeutics, Inc. | SVP, Finance, Chief Acct Offcr | Buy | 5,714 | $7.00 | $39,998.00 | +33.7% | -9.1% | -65.8% |